Loading data for BLCO — first visit, this takes a few seconds.

Bausch + Lomb Corporation

NYSE: BLCO · Real-Time Price · USD
17.20
-0.25 (-1.43%)
At close: Aug 19, 2026, 3:59 PM
17.20
+0.00%
After-hours: 4:10 PM

Bausch + Lomb Corporation (BLCO) Stock Price, Analysis & Data

-1.43%
Bidn/a
Market Cap6.14B
Revenue (ttm)5.32B
Net Income (ttm)-171M
Beta0.55
EPS (ttm)-0.48
PE Ratio (ttm)n/a
Forward PE15.73
P/B (ttm)0.95
P/S (ttm)1.15
Earnings DateOct 28, 2026
Askn/a
Volume365,214
Avg. Volume (20D)423,820
Open17.33
Previous Close17.45
Day's Range17.04 - 17.46
52-Week Range13.77 - 18.91
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About BLCO

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; a...

Sector Healthcare
IPO Date May 6, 2022
Employees 13,000
Stock Exchange NYSE
Ticker Symbol BLCO
Full Company Profile

Financial Performance

In 2025, Bausch + Lomb's revenue was 5.1B, an increase of 6.47% compared to the previous year's 4.79B. Earnings were -360M, an increase of 13.56%.

Financial Statements

Earnings Surprise

Bausch + Lomb has released their quarterly earnings on Jul 29, 2026:
  • Revenue of $1.39B misses estimates by $0, with 9.08% YoY growth.
  • EPS of 0.16 misses estimates by 0.00, with 128.57% YoY growth.
  • Bausch + Lomb Corporation is scheduled to release its earnings on Oct 28, 2026, before market opens.
    Analysts project revenue of ... Upgrade